BSF Enterprise Plc (BSFAF)

OTCMKTS · Delayed Price · Currency is USD
0.0160
+0.0029 (22.14%)
At close: Mar 30, 2026
Market Cap3.48M -18.9%
Revenue (ttm)71.03K -8.6%
Net Income-1.50M
EPS-0.15
Shares Outn/a
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume10,000
Average Volume68,583
Open0.0160
Previous Close0.0131
Day's Range0.0160 - 0.0160
52-Week Range0.0126 - 0.0822
Beta3.59
RSI32.35
Earnings DateJun 26, 2026

About BSF Enterprise

BSF Enterprise Plc, together with its subsidiaries, develops and commercializes cell-based tissue engineering solutions in the United Kingdom and Hong Kong. The company acquires businesses in the biotechnology, marketing, and e-commerce sectors. It also engages in biotechnology start-up; lab-grown cornea and meat research; and development of skin technology. The company was incorporated in 2018 and is based in London, the United Kingdom. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2018
Employees 14
Stock Exchange OTCMKTS
Ticker Symbol BSFAF

Financial Performance

In fiscal year 2025, BSF Enterprise's revenue was 52,840, a decrease of -8.61% compared to the previous year's 57,821. Losses were -1.11 million, -33.41% less than in 2024.

Financial numbers in GBP Financial Statements

News

BSF Enterprise PLC Announces Participation in The ThinkEquity Conference

London, United Kingdom--(Newsfile Corp. - October 5, 2023) - BSF Enterprise PLC (LSE: BSFA) (OTCQB: BSFAF), a company focused on unlocking the next generation of biotechnological solutions using cell-...

2 years ago - Newsfile Corp

BSF Enterprise PLC Provides City-MixTM Bio-Pharmaceutical Update

LONDON, July 18, 2023 (GLOBE NEWSWIRE) -- BSF Enterprise PLC ("BSF" or the "Company") (LSE: BSFA), (OTCQB: BSFAF), a company focused on unlocking the next generation of biotechnological solutions usin...

3 years ago - GlobeNewsWire